Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
39 hedge funds and large institutions have $49.2M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
18% more capital invested
Capital invested by funds: $41.6M → $49.2M (+$7.52M)
8% more funds holding
Funds holding: 36 → 39 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.7M |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$2.33M |
| 3 |
PA
Perceptive Advisors
New York
|
+$2.03M |
| 4 |
SR
Summer Road
West Palm Beach,
Florida
|
+$2.03M |
| 5 |
RA
Royce & Associates
New York
|
+$1.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$430K |
| 2 |
AIP
ARS Investment Partners
New York
|
-$418K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$89.5K |
| 4 |
Renaissance Technologies
New York
|
-$78.3K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$56.1K |
CORV Hedge Fund Activity: Q3 2019 in Review
39 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2019, worth a combined $49.2M — up 18% from $41.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CORV positions and 3 closed out — a net gain of 3 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was Putnam Investments, adding an estimated $2.7M. The largest seller was Essex Investment Management, cutting an estimated $430K.
- 39 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2019, up from 36 in Q2 2019.
- Funds reported $49.2M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2019, up 18% quarter-over-quarter.
- 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2019 and 3 closed out, a net change of +3 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2019 was Putnam Investments, an estimated $2.7M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2019 was Essex Investment Management, an estimated $430K sold.
Based on aggregated 13F filings for Q3 2019.